Michael B Bottorff

Clinical pharmacokinetics and pharmacodynamics of cardiovascular drugs, concentration-effect modeling, clinical pharmacology of beta-blockers and antiarrhythmics, polymorphic drug metabolism, hepatic enzyme inhibition and induction and informatics.

Investigators:Shelly Wiest and Shauna Buring, PIs 07-01-2008 -06-30-2009 American System of Health System Pharmacists Evaluation of the Impact of Pharmacy Practice on Patient Outcomes Role:Collaborator $75,000 Pending Type:Grant Level:National

Peer Reviewed Publications

Bottorff MB, Nutescu EA, Spinler S (2007. ) Antiplatelet therapy in patients with unstable angina and non-ST-segment-elevation myocardial infarction: findings from the CRUSADE national quality improvement initiative.Pharmacotherapy, , 27 (8 ) ,1145-62 More Information

Bottorff MB (2008. ) The safety of triple therapy with warfarin, aspirin and clopidogrel.Acute Coronary Syndromes, , 9 , More Information

Book Chapter

Bottorff MB (2008 ) Pharmacists Handbook on Lipid Management Non-drug therapies for reductions in abnormal lipids .Lenexa, KS, American College of Clinical Pharmacy (Author)

Pharmacists Handbook on Lipid Management

Bottorff MB and Doherty M (2008 ) Textbook of Therapeutics, Drug and Disease Management Management of Dyslipidemias .Philadelphia, Lippincott Williams and Wilkins (Author)

Management of Dyslipidemias

Bottorff MB and Hein B (2008 ) Cardiology Secrets Warfarin .Philadelphia, PA, Elsevier (Author)

Cardiology Secrets

Invited Presentations

Bottorff MB (07-24-2007. ) Management of Hypertension in Diabetic Nephropathy .Primary Care CE Program, Anchorage, AL. Professional Meeting. . Level:National

Bottorff MB (09-21-2007. ) Lipid management beyond LDL reduction .Primary Care CME meeting, Las Vegas, NV. Professional Meeting. . Level:National

Bottorff MB (09-24-2007. ) Aggtressive lipid management .Grand Rounds, Good Samaritan Hospital, Dayton, OH. Other Institution. . Level:Department

Bottorff MB (09-28-2007. ) Safety of drugs for lipid disorgers .National Lipid Association, Minneapolis, MN. Professional Meeting. . Level:National

Bottorff MB (10-03-2007. ) Case Management of Elevated Lipids .PRIMED Pharmacy CE Meeting, Houston, TX. Professional Meeting. . Level:Regional

Bottorff MB (10-13-2007. ) Safety standards for antiplatelet drugs in acute coronary syndromes .American College of Clinical Pharmacy National Meeting, Denver, CO. Professional Meeting. . Level:National

Bottorff MB (11-02-2007. ) Event reduction in the at risk patient .Interdisciplinary CE, Greenbriar, WV. Conference. . Level:Regional

Bottorff MB (11-14-2007. ) Pathophysiology of Acute Coronary Syndromes .National Meeting of American Society for Consultant Pharmacists, Philadelphia, PA. Professional Meeting. . Level:National

Bottorff MB (12-04-2007. ) Safety considerations in acute coronary syndromes .National Meeting American Society for Health Systems Pharmacists, Las Vegas, NV. Professional Meeting. . Level:National

Bottorff MB (02-02-2008. ) The impact of raising HDL cholesterol .Continuing medical education, Minneapolis. Professional Meeting. . Level:Regional

Bottorff MB (05-16-2008. ) Amiodarone for atrial fibrillation in the elderly .Natinoal Meeting American Society for Consultant Pharmacists, Las Vegas, NV. Professional Meeting. . Level:National

Bottorff MB (06-19-2008. ) Antiplatelet drugs for acute coronary syndromes .National Case Managers Meeting, Orlando, FL. Professional Meeting. . Level:National

Journal of Clinical Lipidology Editorial Board Member 07-2007

07-1991 -To Present: American Heart Association

07-2005 -To Present: National Lipid Association